Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials

The effects of darunavir-ritonavir at 600 and 100 mg twice daily (b.i.d.) alone, 200 mg of etravirine b.i.d. alone, or 600 and 100 mg of darunavir-ritonavir b.i.d. with 200 mg etravirine b.i.d. at steady state on the steady-state pharmacokinetics of maraviroc, and vice versa, in healthy volunteers w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kakuda, Thomas N., Abel, Samantha, Davis, John, Hamlin, Julia, Schöller-Gyüre, Monika, Mack, Rebecca, Ndongo, Noella, Petit, Wendy, Ridgway, Caroline, Sekar, Vanitha, Tweedy, Sarah, Hoetelmans, Richard M. W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2011
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3088221/
https://ncbi.nlm.nih.gov/pubmed/21383098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01046-10
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller